HIGHLIGHTS
- What: The US approval for the first human photoimmunotherapy (PIT) trial focused on incurable head and neck cancer.28 FDA (Food and Drug Administration) National Journal of Community Medicine│Volume 15│Issue 12│December 2024 reports that phase III international clinical studies will start in 2018. The aims of this vital initial phase in converting research into practical applications are to reduce chemical toxicity and improve therapeutic benefits. This approach has been used in clinical trials on gliomas and prostate cancer . Treatment of different tumors is the main goal of gene therapy clinical trials today .
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.